• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Global Liquid Biopsy Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
The global liquid biopsy market was valued at US$ 1,824.7 million in 2016 and is expected to
witness a robust CAGR of 18.3% over the forecast period (2017–2025).
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/1223
Some major players operating in the liquid biopsy market include Illumina, Inc., Roche AG,
Natera, Inc., Laboratory Corporation of America Holdings (LabCorp), Qiagen N.V., Thermo
Fisher Scientific Inc., Exact Sciences Corp., Biocept, Inc., Genomic Health, Inc., Guardant
Health, TrovaGene Inc., CareDx Inc., Adaptive Biotechnologies Corporation, and Biocartis SA.
Detailed Segmentation:
• Global Liquid Biopsy Market, By Products & Services:
• Reagents & Kits
• Equipments
• Services
• Global Liquid Biopsy Market, By Sample:
• Cell Free DNA (cfDNA)
• Circulating Tumor Cells (CTC)
• Exosomes
• Global Liquid Biopsy Market, By Application:
• Oncology Testing
• Noninvasive Prenatal Testing
• Transplant Care
• Global Liquid Biopsy Market, By End User:
• Hospitals
• Research Laboratories
• Diagnostic Laboratories
• Patients